
### [MONDO:0001982](http://purl.obolibrary.org/obo/MONDO_0001982)
**Label:** Niemann-Pick disease

**Subclasses:** [MONDO:0011871](http://purl.obolibrary.org/obo/MONDO_0011871) (Niemann-Pick disease type b), 

**Corr. equiv. classes:** [Orphanet:99022](http://www.orpha.net/ORDO/Orphanet_99022), [OMIM:607616](http://purl.obolibrary.org/obo/OMIM_607616), [Orphanet:77293](http://www.orpha.net/ORDO/Orphanet_77293), 

**Class expressions from DL-Learner:**

- [HP:0002207](http://purl.obolibrary.org/obo/HP_0002207) (Diffuse reticular or finely nodular infiltrations) and [HP:0010981](http://purl.obolibrary.org/obo/HP_0010981) (Hypolipoproteinemia) 66.67%
- [HP:0002207](http://purl.obolibrary.org/obo/HP_0002207) (Diffuse reticular or finely nodular infiltrations) and [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) 66.67%
- [HP:0002207](http://purl.obolibrary.org/obo/HP_0002207) (Diffuse reticular or finely nodular infiltrations) and [HP:0010979](http://purl.obolibrary.org/obo/HP_0010979) (Abnormality of the level of lipoprotein cholesterol) 66.67%
- [HP:0002207](http://purl.obolibrary.org/obo/HP_0002207) (Diffuse reticular or finely nodular infiltrations) and [HP:0003812](http://purl.obolibrary.org/obo/HP_0003812) (Phenotypic variability) 66.67%
- [HP:0002207](http://purl.obolibrary.org/obo/HP_0002207) (Diffuse reticular or finely nodular infiltrations) and [HP:0003621](http://purl.obolibrary.org/obo/HP_0003621) (Juvenile onset) 66.67%
- [HP:0002207](http://purl.obolibrary.org/obo/HP_0002207) (Diffuse reticular or finely nodular infiltrations) and [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) 66.67%
- [HP:0002207](http://purl.obolibrary.org/obo/HP_0002207) (Diffuse reticular or finely nodular infiltrations) and [HP:0003141](http://purl.obolibrary.org/obo/HP_0003141) (Increased circulating low-density lipoprotein levels) 66.67%
- [HP:0002207](http://purl.obolibrary.org/obo/HP_0002207) (Diffuse reticular or finely nodular infiltrations) and [HP:0003119](http://purl.obolibrary.org/obo/HP_0003119) (Abnormality of lipid metabolism) 66.67%
- [HP:0002207](http://purl.obolibrary.org/obo/HP_0002207) (Diffuse reticular or finely nodular infiltrations) and [HP:0003107](http://purl.obolibrary.org/obo/HP_0003107) (Abnormality of cholesterol metabolism) 66.67%
- [HP:0002207](http://purl.obolibrary.org/obo/HP_0002207) (Diffuse reticular or finely nodular infiltrations) and [HP:0003077](http://purl.obolibrary.org/obo/HP_0003077) (Hyperlipidemia) 66.67%
- [HP:0002207](http://purl.obolibrary.org/obo/HP_0002207) (Diffuse reticular or finely nodular infiltrations) and [HP:0002795](http://purl.obolibrary.org/obo/HP_0002795) (Functional respiratory abnormality) 66.67%
- [HP:0002155](http://purl.obolibrary.org/obo/HP_0002155) (Hypertriglyceridemia) and [HP:0002207](http://purl.obolibrary.org/obo/HP_0002207) (Diffuse reticular or finely nodular infiltrations) 66.67%
- [HP:0002094](http://purl.obolibrary.org/obo/HP_0002094) (Dyspnea) and [HP:0002207](http://purl.obolibrary.org/obo/HP_0002207) (Diffuse reticular or finely nodular infiltrations) 66.67%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0002207](http://purl.obolibrary.org/obo/HP_0002207) (Diffuse reticular or finely nodular infiltrations) 66.67%
- [HP:0001103](http://purl.obolibrary.org/obo/HP_0001103) (Abnormal macular morphology) and [HP:0002207](http://purl.obolibrary.org/obo/HP_0002207) (Diffuse reticular or finely nodular infiltrations) 66.67%



### [MONDO:0001982](http://purl.obolibrary.org/obo/MONDO_0001982)
**Label:** Niemann-Pick disease

**Subclasses:** [MONDO:0011871](http://purl.obolibrary.org/obo/MONDO_0011871) (Niemann-Pick disease type b), 

**Corr. equiv. classes:** [Orphanet:99022](http://www.orpha.net/ORDO/Orphanet_99022), [OMIM:607616](http://purl.obolibrary.org/obo/OMIM_607616), [Orphanet:77293](http://www.orpha.net/ORDO/Orphanet_77293), 

**Class expressions from DL-Learner:**

- [HP:0002207](http://purl.obolibrary.org/obo/HP_0002207) (Diffuse reticular or finely nodular infiltrations) and [HP:0010981](http://purl.obolibrary.org/obo/HP_0010981) (Hypolipoproteinemia) 66.67%
- [HP:0002207](http://purl.obolibrary.org/obo/HP_0002207) (Diffuse reticular or finely nodular infiltrations) and [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) 66.67%
- [HP:0002207](http://purl.obolibrary.org/obo/HP_0002207) (Diffuse reticular or finely nodular infiltrations) and [HP:0010979](http://purl.obolibrary.org/obo/HP_0010979) (Abnormality of the level of lipoprotein cholesterol) 66.67%
- [HP:0002207](http://purl.obolibrary.org/obo/HP_0002207) (Diffuse reticular or finely nodular infiltrations) and [HP:0003812](http://purl.obolibrary.org/obo/HP_0003812) (Phenotypic variability) 66.67%
- [HP:0002207](http://purl.obolibrary.org/obo/HP_0002207) (Diffuse reticular or finely nodular infiltrations) and [HP:0003621](http://purl.obolibrary.org/obo/HP_0003621) (Juvenile onset) 66.67%
- [HP:0002207](http://purl.obolibrary.org/obo/HP_0002207) (Diffuse reticular or finely nodular infiltrations) and [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) 66.67%
- [HP:0002207](http://purl.obolibrary.org/obo/HP_0002207) (Diffuse reticular or finely nodular infiltrations) and [HP:0003141](http://purl.obolibrary.org/obo/HP_0003141) (Increased circulating low-density lipoprotein levels) 66.67%
- [HP:0002207](http://purl.obolibrary.org/obo/HP_0002207) (Diffuse reticular or finely nodular infiltrations) and [HP:0003119](http://purl.obolibrary.org/obo/HP_0003119) (Abnormality of lipid metabolism) 66.67%
- [HP:0002207](http://purl.obolibrary.org/obo/HP_0002207) (Diffuse reticular or finely nodular infiltrations) and [HP:0003107](http://purl.obolibrary.org/obo/HP_0003107) (Abnormality of cholesterol metabolism) 66.67%
- [HP:0002207](http://purl.obolibrary.org/obo/HP_0002207) (Diffuse reticular or finely nodular infiltrations) and [HP:0003077](http://purl.obolibrary.org/obo/HP_0003077) (Hyperlipidemia) 66.67%
- [HP:0002207](http://purl.obolibrary.org/obo/HP_0002207) (Diffuse reticular or finely nodular infiltrations) and [HP:0002795](http://purl.obolibrary.org/obo/HP_0002795) (Functional respiratory abnormality) 66.67%
- [HP:0002155](http://purl.obolibrary.org/obo/HP_0002155) (Hypertriglyceridemia) and [HP:0002207](http://purl.obolibrary.org/obo/HP_0002207) (Diffuse reticular or finely nodular infiltrations) 66.67%
- [HP:0002094](http://purl.obolibrary.org/obo/HP_0002094) (Dyspnea) and [HP:0002207](http://purl.obolibrary.org/obo/HP_0002207) (Diffuse reticular or finely nodular infiltrations) 66.67%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0002207](http://purl.obolibrary.org/obo/HP_0002207) (Diffuse reticular or finely nodular infiltrations) 66.67%
- [HP:0001103](http://purl.obolibrary.org/obo/HP_0001103) (Abnormal macular morphology) and [HP:0002207](http://purl.obolibrary.org/obo/HP_0002207) (Diffuse reticular or finely nodular infiltrations) 66.67%


